Chargeback ratios for CBD multi-brand

The biggest mistake we see CBD multi-brand operators make isn't missing the 1.0% Visa threshold. It's not knowing their per-brand chargeback ratio because they measure the whole portfolio together, average it out, and miss the one brand that's at 1.4% dragging everything into acquirer review. Here's how chargeback ratios actually work for CBD operators running 3+ brands, and how to structure the measurement so your risk team catches problems before acquirers do.

The three ratios that matter

Every CBD operator should be tracking three separate chargeback ratios, monthly, at minimum. First, count-based ratio: chargebacks divided by total transaction count, month over month. This is what Visa VAMP measures. Second, dollar-based ratio: chargeback dollars divided by total processed dollars. This is what your acquirer internally watches. Third, dispute-to-refund ratio: a customer who requests a refund before disputing costs you the product cost; a customer who disputes first costs you product cost plus chargeback fee plus ratio impact. Operators with strong CX teams see 4:1 refund-to-dispute; weak CX teams see 1:2.

VAMP (the Visa Acquirer Monitoring Program) tightened in 2024 to combine disputes and excessive refunds. Multi-brand CBD operators now need to manage both. A 0.9% dispute ratio that looks safe can still trigger VAMP if refunds are running high. See our full 2026 chargeback ratio guide for the current card-brand thresholds.

Why CBD specifically faces tighter ratios

CBD MCCs (primarily 5912 pharmacy, 5977 cosmetics, 5999 misc retail depending on acquirer) are classified as higher-risk under both Visa and Mastercard monitoring. The practical result: the 1.0% Visa chargeback threshold applies universally, but CBD operators get flagged by their acquirer at 0.65% and reviewed at 0.9% — well before the card brands step in. Mastercard's Excessive Chargeback Merchant (ECM) program kicks in at 1.5% dispute rate with 100+ chargebacks in a month; CBD MIDs see that scrutiny at lower volumes.

Stripe, Square, and PayPal still decline most CBD, so CBD operators run on specialist ISOs like Corepay, Durango, and PayKings. Those ISOs have less tolerance for ratio drift because their own acquirer relationship depends on not letting CBD book ratios drift above 1%. One brand goes over, the whole portfolio gets reviewed.

Per-brand vs portfolio-level measurement

This is where multi-brand CBD operators get burned. If you have five brands — topicals, ingestibles, pet, sport, flower — each brand has its own chargeback personality. Pet CBD sees 0.3% disputes. Hemp flower sees 0.8%. Put them together on one portfolio report and you see 0.5% and breathe easy. But the hemp flower brand is one bad cohort away from 1.0% and closure, while the portfolio average masks the risk.

The right structure: each brand has its own MID (or soft-descriptor under a parent), and your risk dashboard shows per-brand dispute ratio month-over-month. When flower hits 0.65%, you act on that brand — tighten 3DS, tighten CVV mismatch rules, raise the refund threshold in CX, review the recent ad creative for "risk-free trial" language. Without per-brand visibility you don't know which brand is the problem until the acquirer tells you.

What the measurement window should be

Card brands measure on the dispute-posted date, not the transaction date. A chargeback that comes in March on a January transaction hits your March ratio. This creates a lag problem for operators who change something in January and wait for the ratio to move — it won't move until April or May.

For CBD portfolios we recommend two views: the card-brand view (disputes posted this month / transactions posted this month) because that's what acquirers see, and the cohort view (chargebacks filed against transactions from month N, divided by transaction count in month N) because that's what tells you whether your interventions are working. The card-brand view is the compliance number; the cohort view is the operational number.

Practical thresholds for CBD multi-brand

Target: sub-0.65% portfolio-level dispute ratio, no single brand above 0.9% for two consecutive months. Alert: any brand crossing 0.5% (act in CX before the acquirer emails). Emergency: any brand above 0.9% — immediately pull the last 30 days of that brand's data, find the pattern (usually one campaign or one cohort), isolate and fix. See CBD chargeback fraud prevention for the tactical playbook.

For portfolios running parent-account orchestration (our model), the risk dashboard shows per-brand ratio in real time and auto-alerts when a brand crosses 0.5%. That's the whole point of running the parent architecture instead of N separate ISOs — you get portfolio-level risk management with per-brand granularity.

Talk to the risk desk

If you're running 3+ CBD brands and your portfolio ratio is above 0.5%, you're one acquirer review away from a reserve bump. Submit an application and we'll audit per-brand ratios in the first consult — free, no contract. See also the CBD operator playbook.